CD8+ T cells have been classically viewed as the predominant effector responsible for anti-tumor immune responses due to its direct tumor-killing feature, while CD4+ T cells function as auxiliary roles by promoting the priming and differentiation of naive CD8+ T cells (33, 34). This evidence concerns the gene CD4 and neoplasm.